AstraZeneca’s experimental lupus drug fails to meet main goal in study

(Reuters) – AstraZeneca’s experimental lupus drug failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday. AstraZeneca’s anifrolumab, which is given intravenously, was being developed for … Continue reading AstraZeneca’s experimental lupus drug fails to meet main goal in study